DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Indo Count Industries Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 1 hr ago·12 Oct 2026, 4:44 am

Indo Count Industries

Indo Count Industries Limited has informed stock exchanges that it has received a certificate under SEBI’s Depositories and Participants Regulations, 2018. This regulatory filing confirms that the company has successfully complied with the requirements set by the Securities and Exchange Board of India for its depository activities. The certificate is a standard administrative requirement that validates the company’s adherence to the rules governing securities transactions and investor protection.

For investors, this update is largely procedural and does not signal any major operational changes. It serves as a compliance milestone, ensuring the company’s depository processes are in order. While the news is neutral, it reinforces the company’s commitment to regulatory standards. Investors should monitor the stock for any further disclosures or market reactions, but this specific filing is not expected to have a significant short-term impact on the company's fundamentals.